Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
18.52B | 20.30B | 20.40B | 17.57B | 17.09B | Gross Profit |
7.35B | 8.15B | 8.57B | 7.61B | 7.91B | EBIT |
3.15B | 3.94B | 4.70B | 3.83B | 4.09B | EBITDA |
9.61B | 17.02B | 5.88B | 6.45B | 4.86B | Net Income Common Stockholders |
6.01B | 10.30B | 3.36B | 3.82B | 2.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
16.07B | 18.02B | 16.25B | 13.00B | 13.91B | Total Assets |
80.29B | 78.70B | 64.53B | 57.59B | 56.69B | Total Debt |
22.05B | 21.83B | 18.92B | 11.58B | 13.72B | Net Debt |
5.99B | 13.89B | 2.67B | -1.42B | -187.46M | Total Liabilities |
26.43B | 29.11B | 22.18B | 14.93B | 15.98B | Stockholders Equity |
53.86B | 49.58B | 42.36B | 42.66B | 40.71B |
Cash Flow | Free Cash Flow | |||
-117.58M | 2.24B | -97.74M | 2.64B | 4.44B | Operating Cash Flow |
1.89B | 4.97B | 3.75B | 3.21B | 5.46B | Investing Cash Flow |
1.19B | -5.58B | -8.09B | -506.70M | -4.68B | Financing Cash Flow |
-1.64B | -492.22M | 3.76B | -3.94B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥62.10B | 11.95 | 2.19% | 5.66% | 29.61% | ||
76 Outperform | ¥10.14B | 8.33 | 3.84% | 6.35% | 15.42% | ||
76 Outperform | ¥24.18B | 7.75 | 4.09% | 6.40% | 31.47% | ||
72 Outperform | ¥25.68B | 12.24 | 5.19% | 0.61% | -31.44% | ||
67 Neutral | ¥26.14B | 4.84 | 4.88% | -8.79% | -39.49% | ||
62 Neutral | ¥3.12B | 25.42 | 1.23% | 7.00% | -4.02% | ||
44 Neutral | C$959.44M | -6.67 | -13.31% | 2.72% | 17.60% | -31.88% |